Targovax ASA operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Targovax ASA with three other
miscellaneous service companies in Europe:
Oryzon Genomics Sa
of Spain
(2017
sales of 16,764.00 Euro [US$20,747.46 ]
),
Neurovive Pharmaceutical AB
of Sweden
(27,000.00 Swedish Kronor [US$3,212.73 ]
of which 100%
was Neurostat), and
Immunovia AB (publ)
which is
also
based in Sweden
(148,963.00 Swedish Kronor [US$17,725.11 ]
).
Sales Analysis.